summary: In MS, health-related quality of life (HRQOL) is reduced. However, it is not yet well established that measures related to quality of life are to be taken into account as outcome measures in clinical trials. In this study the authors have shown that there is a significant association between MRI characteristics such as lesion burden and brain volume loss and HRQOL. These findings strengthen the argument for the use of HRQOL outcome measures in clinical trials.

authors: Mowry EM, Beheshtian A, Waubant E, Goodin DS, Cree BA, Qualley P, Lincoln R, George MF, Gomez R, Hauser SL, Okuda DT, Pelletier D

source: Neurology. 2009 May 19;72(20):1760-5

weblink: click here

category: Imaging
category: Health Status Assessment and Quality of Life

related research news: click here

glossary: